- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 11, 2026 | 21.08M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 21.08M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 21.07M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 21M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 19.16M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $17.25K |
| Capex | Q3 2026 · Mar 31, 2025 | $41.45K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$3.47M |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | −$116.53K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $2.15M |
| Cash And Equivalents | Q3 2026 · Mar 30, 2026 | $2.15M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $6.83M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $2.71M |
| Stockholders Equity | Q3 2026 · Mar 30, 2026 | $2.71M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $15.25M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $16.94M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $16.73M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $17.92M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $11.54M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.60 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.71 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.07 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.13 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.60 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.71 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.13 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $626.14K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $2.45M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $1.17M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $2.95M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $1.53M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $3.4M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $829.82K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $2.61M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$12.68M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$14.94M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.5M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$2.49M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$12.71M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$15.3M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.58M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$2.61M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $584.1K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $2.38M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $1.02M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $4.97M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $290K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $290K |
| Revenue | Q3 2026 · Mar 31, 2026 | $657.46K |
| Revenue | Q3 2026 · Mar 31, 2026 | $3.36M |
| Revenue | Q3 2026 · Mar 31, 2025 | $1.42M |
| Revenue | Q3 2026 · Mar 31, 2025 | $7.03M |
| Current Liabilities | Q3 2026 · Mar 30, 2026 | $1.04M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $2.34M |
| Total Liabilities | Q3 2026 · Mar 30, 2026 | $1.05M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $2.34M |
| Current Assets | Q3 2026 · Mar 30, 2026 | $3.54M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $8.17M |
| Total Assets | Q3 2026 · Mar 30, 2026 | $3.75M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $19.28M |